Efficacy of Potassium Permanganate in Treating Ichthyophthiriasis in Channel Catfish

Abstract

Epizootics of ichthyophthiriasis can be controlled with potassium permanganate (KMnO₄), but its effectiveness has not been confirmed by controlled studies. The purpose of this study was to determine the concentration of KMnO₄ needed to halt an active Ichthyophthirius multifiliis infestation in channel catfish Ictalurus punctatus. Juvenile channel catfish were exposed to fish infested with I. multifiliis until they developed immature trophonts. They were then moved to individual static containers with 2 L of filtered well water, where they were treated with KMnO₄ daily for 10 d. The lowest effective dose of KMnO₄ required to eliminate theronts was 1.25 mg/L. The results indicate that KMnO₄ is effective for controlling I. multifiliis epizootics at low concentrations in clean water. However, effective treatment in ponds will be strongly influenced by detoxication of KMnO₄ depending on the concentration of easily oxidizable substances in the water.     

Impact of dietary manganese concentration on status criteria to determine manganese requirement in piglets

The Mn requirement for pigs is not well established. This study aimed to find criteria for assessing growing piglet supply status for Mn and to determine whether the current Mn recommendations meet the requirements for piglets. Thirty‐six weaned male castrated 27‐day‐old piglets (7.24 ± 0.69 kg) were randomized into six groups of six piglets each and housed individually in stainless steel metabolic cages for 42 days. The piglets were fed a diet based on skimmed milk powder and corn starch with increasing Mn concentrations (0.24; 2; 4; 8; 16; or 32 mg Mn/kg diet as‐fed). In week 6, Mn0.24 led to reduced feed intake (p < 0.05). Manganese concentrations in blood, liver, kidney, lung, heart, phalanx proximalis, pancreas and skeletal muscle were influenced by the dietary Mn supply (p < 0.05). The activity of the Mn‐containing superoxide dismutase in the heart as well as relative arginase activity in the liver were lower in groups Mn0.24, Mn2 and Mn4 compared with the higher supplemented groups (p < 0.05). The relative arginase activity increased clearly with enhanced dietary Mn up to 16 mg/kg and correlated with Mn concentration in the liver. Manganese concentrations in the liver, kidney and phalanx proximalis seem to be suitable biomarkers for Mn status. A 4 mg/kg dietary Mn concentration recommended by NRC (1998, Nutrient Requirements of Swine. National Academy Press, Washington DC.) did not fulfil piglet requirements. Under the conditions investigated, 16 mg Mn/kg diet were necessary to reach a plateau in specific enzyme activity and Mn concentration in organs.     

口服福尔马林对羔羊消化代谢与生长的影响

将8只30日龄、体重(6.9±1.0)kg的小尾寒羊×无角陶赛特母羔羊随机分为2组(每组4只),以研究口服福尔马林对羔羊自由采食、消化代谢、屠宰性能和甲醛残留的影响。结果表明,在55～80、95～120和125～150日龄3个日龄段,对照组羔羊的干物质采食量分别为(567.3±27.5)、(752.4±9.01)和(1044.1±30.8)g/(d.头),口服福尔马林组分别增加22.02%(P0.01)、28.75%(P0.01)和41.79%(P0.01);对照组羔羊的氮保留分别为(12.3±0.8)、(13.6±0.2)和(18.0±0.6)g/(d.头),口服福尔马林组分别增加25.20%(P0.01)、41.91%(P0.01)和46.11%(P0.01);对照组羔羊的日增重分别为(157.1±11.7)、(246.4±24.4)和(250.0±8.3)g/(d.头),口服福尔马林组分别增加18.20%(P0.05)、23.21%(P0.05)和27.16%(P0.01);而两组间的日粮消化率无显著差异。240日龄对照组和口服福尔马林组羔羊的胴体重分别为(20.37±1.78)和(24.55±1.14)kg/头(P0.01),屠宰率分别为48.59%±1.08%和50.46%±1.02%(P0.05),瘦肉率分别为65.22%±1.57%和64.84%±1.11%(P0.05)。羔羊血液、肌肉、肾脏、肝脏、瘤胃组织和小肠组织中的甲醛含量对照组分别为(1.84±0.44)mg/L、(0.35±0.26)mg/kg、(1.10±0.67)mg/kg、(0.74±0.34)mg/kg、(0.91±0.72)mg/kg和(0.79±0.41)mg/kg,在试验组分别为(1.47±0.61)mg/L、(0.54±0.34)mg/kg、(1.65±0.71)mg/kg、(0.91±0.38)mg/kg、(2.03±0.71)mg/L和(0.85±0.42)mg/L。因此,口服福尔马林可增加羔羊的自由采食量而不影响消化率,提高羔羊对日粮的消化量和羔羊日增重;以上这种作用随羔羊的日龄增加而增强;口服福尔马林提高羔羊的胴体重、屠宰率,但不影响胴体的瘦肉率;长期口服福尔马林羔羊的组织器官中甲醛的含量低于2.0 mg/kg。     

Serum pharmacokinetics of oxytetracycline in sheep and calves and tissue residues in sheep following a single intramuscular injection of a long-acting preparation

The pharmacokinetics of a long‐acting oxytetracycline (OTC) formulation (Liquamycin® LA‐200®) injected intramuscularly (i.m.) at a dose of 20 mg/kg were determined in four calves and 24 sheep to determine if the approved label dose for cattle provided a similar serum time/concentration profile in sheep. The AUC for the calves was 168±14.6 (μg ? h/mL) and was significantly less than the AUC for sheep (209±43 μg ? h/mL). Using the standard two‐stage approach and a one‐compartment model, the mean Cmax for the calves was 5.2±0.8 μg/mL, and for the sheep was 6.1±1.3 μg/mL. The mean terminal phase rate constants were 0.031 and 0.033 h, and the Vdss were 3.3 and 3.08 L/kg for the calves and sheep respectively. Analysis of the data using the standard two‐stage approach, the naive pooled‐data approach and a population model gave very similar results for both the cattle and sheep data. Sheep tissue residues of OTC in serum, liver, kidney, fat, muscle and injection site were measured at 1, 2, 3, 5, 7 and 14 days after a single i.m. injection of 20 mg/kg OTC. Half‐lives of OTC residues in the tissues were 38.6, 33.4, 28.6, 25.4, 21.3, and 19.9 h for injection site, kidney, muscle, liver, mesenteric fat and renal fat, respectively. The ratio of tissue to serum concentration was fairly consistent at all slaughter times, except for the fat and injection sites. The mean ratios were 1.72, 4.19, 0.11, 0.061, 0.84 and 827 for the liver, kidney, renal fat, mesenteric fat, muscle and injection sites, respectively. The tissue concentrations of OTC residues were below the established cattle tolerances for OTC in liver (6 p.p.m.), muscle (2 p.p.m.) and kidney (12 p.p.m.) by 48 h, and in injection site muscle by 14 days after the single i.m. injection of 20 mg/kg.     

Effect of Temperature and Dissolved Oxygen Concentration on Edwardsiella ictaluri in Experimentally Infected Channel Catfish

Abstract

Channel catfish Ictalurus punctatus were experimentally infected with Edwardsiella ictaluri by immersion exposure. After clinical disease ran its course for 52 d, the surviving fish were exposed to one of the following environmental regimes in troughs: 25°C with aeration, 25°C with no aeration, or variable temperature (18–23°C) with no aeration. After 29 d of exposure to the environmental regimes, various organs and tissues of the fish were assayed to determine the effects of these conditions on E. ictaluri concentrations (colony-forming units/mL of tissue sample). The concentrations of this pathogen were significantly (P < 0.05) higher in all tissues (trunk kidney, liver, head kidney, blood, spleen, gallbladder, muscle, brain, and gonad) 52 d postinfection than 29 d after exposure to any of the environmental regimes (81 d postinfection). Fish exposed to a near-normal concentration of dissolved oxygen (6.4 mg/L) and a constant temperature of 25°C had E. ictaluri concentrations that were significantly (P < 0.01) lower than those offish exposed to a low oxygen concentration (2.6 or 1.8 mg/L) and either a constant or a variable temperature.     

The Effect of High Total Ammonia Concentration on the Survival of Channel Catfish Experimentally Infected with Flavobacterium columnare

Abstract

Ammonia concentrations in water can affect the severity of Flavobacterium columnare infections in fish. Two trials lasting 7 d each were conducted to determine the effect of a single immersion flush treatment of total ammonia nitrogen (TAN; 15 mg/L) on the survival of channel catfish Ictalurus punctatus infected with F. columnare; the chemical was added while the water flowed continuously through the tanks. Both trials consisted of four treatments: (1) no ammonia exposure and no bacterial challenge (control), (2) ammonia exposure only, (3) bacterial challenge only, and (4) both ammonia exposure and bacterial challenge. Two hours after exposure to ammonia, the highest un-ionized ammonia level was 0.43 mg/L. The percent un-ionized ammonia is based on TAN, temperature, and pH. Caudal fins from three fish in each treatment were sampled at 24 h posttreatment to be analyzed by quantitative real-time polymerase chain reaction (qPCR). No significant difference in survival (mean ± SE) was noted between the channel catfish in treatment 1 (95.2 ± 1.2%) and those in treatment 2 (95.6 ± 1.0%); however, survival in both treatments 1 and 2 differed significantly from that in treatments 3 (8.5 ± 4.5%) and 4 (41.8 ± 12.7%). Treatment 4 catfish had significantly higher survival than treatment 3 catfish. Quantitative PCR data showed that treatment 4 fish had significantly less F. columnare (7.6 × 10⁵) than did treatment 3 fish (1.2 × 10⁷), and treatment 2 fish (8.5 × 10³) had significantly less bacteria than did treatment 1 fish (6.9 × 10⁴), indicating that ammonia limited the F. columnare infection. The highest mean concentration of the bacteria (3.9 × 10⁷) was found on moribund fish. The ammonia concentrations tested did not negatively influence fish survival but interfered with the infection process. An in vitro assay was also conducted to evaluate the direct effects of ammonia on F. columnare.

Received September 15, 2010; accepted May 7, 2011     

肉雏鸡日粮中不同钙、磷、VD_3、锰、锌水平的组合效应的研究

本研究应用５因子５水平部分实施的２次回归几乎正交旋转组合设计，采用玉米－豆粕型基础日粮和４３２只ＡＡ（ＡｒｂｏｒＡｃｒｅｓ）肉用公雏，研究日粮中锰（Ｍｎ）、锌（Ｚｎ）、钙（Ｃａ）、有效磷（ａｖ．Ｐ）、维生素Ｄ３（ＶＤ３）５因素不同添加水平的组合效应，探讨５因素与指标间的相互关系。结果表明，由二次响应面分析得出的生产函数二次曲线稳定点的预测值为３５８．７１，对应５因素组合的预测值分别为Ｃａ＝１．０１％，ａｖ．Ｐ＝０．４９％，ＶＤ３＝２１１０．７５１ＩＵ／ｋｇ，Ｍｎ＝１４１．２５ｍｇ／ｋｇ，Ｚｎ＝１７５．８５ｍｇ／ｋｇ，Ｃａ、ａｖ．Ｐ、Ｚｎ是影响生长的主因素；肉雏鸡日粮中Ｃａ、ａｖ．Ｐ、Ｍｎ、Ｚｎ、ＶＤ３任一因素的添加水平过高都会影响其它４营养素的吸收和利用；Ｍｎ－ＳＯＤ、肝锰、肾锰以及血清钙和磷、肝锌分别是反映Ｍｎ、Ｃａ、ａｖ．Ｐ、Ｚｎ营养状况的敏感指标。     

Pharmacokinetics of flumequine in sheep after intravenous and intramuscular administration: bioavailability and tissue residue studies

The pharmacokinetic properties of flumequine and its metabolite 7-hydroxyflumequine were determined in six healthy sheep after single intramuscular (i.m.) and intravenous (i.v) injections at a dose of 6 mg/kg body weight. The tissue residues were determined in 20 healthy sheep after repeated i.m. administration with a first dose of 12 mg/kg and nine doses of 6 mg/kg. The flumequine formulation used was Flumiquil 3% Suspension Injectable®. The mean plasma concentrations of flumequine after i.v. administration were described by a three-compartment open model with a rapid distribution and a relatively slow elimination phase. The low value of volume of distribution at steady state (V_dss) (0.52 ± 0.24 L/kg) and high value of volume of distribution (V_dλ₃) (5.05 ± 3.47 L/kg) emphasized the existence of a small compartment with a slow rate of return to the central compartment. The mean elimination half-life was 11.5 h. The 7-hydroxyflumequine plasma levels represented 2.3% of the total area under the curve. The mean plasma concentrations of flumequine after i.m. administration were characteristic of a two-compartment model with a first order absorption. The mean maximal plasma concentration (1.83 ± 1.15 μg/mL) was obtained rapidly, i.e. 1.39 ± 0.71 h after the i.m. administration. The fraction of dose absorbed from the injection site was 85.00 ± 30.13%. The minimal concentrations of flumequine during repeated treatment were significantly lower in females than in males. Eighteen hours after the last repeated i.m. admini-stration, the highest concentration of flumequine was observed at the injection sites followed by kidney, liver, muscle and fat. The highest concentration of 7-hydroxyflumequine was observed in the kidney and was ten times lower than the flumequine concentration. The longest flumequine elimination half-life was observed in the fat.     

Lipid Composition of Hepatic and Adipose Tissues From Normal Cats and From Cats With Idiopathic Hepatic Lipidosis

The purpose of this study was to characterize the lipid classes in hepatic and adipose tissues from cats with idiopathic hepatic lipidosis (IHL). Concentrations of triglyceride, phospholipid phosphorus, and free and total cholesterol were determined in lipid extracts of liver homogenates from 5 cats with IHL and 5 healthy control cats. Total fatty acid composition of liver and adipose tissue was also compared. Triglyceride accounted for 34% of liver by weight in cats with IHL (338 ± 38 mg/g wet liver) versus 1% in control cats {9.9 ±1.0 mg/g wet liver, P < .001). The mass of cholesterol ester was significantly higher in triglyceride-free (TG-free) liver from cats with IHL (741 ± 340 μg/g TG-free wet liver) compared to healthy cats (31 ± 11 μg/g TG-free wet liver, P < .05). Total fatty acid composition of hepatic tissue in the 2 groups differed; pa Imitate was higher (19.5 ± 1.1% of total fatty acids in cats with IHL versus 9.2 ± 2.7% in controls, P < .05), stearate was lower (8.5 ± 0.8% versus 16.8 ± 1.1%, P < .05), oleate was higher (41.2 ± 1.6% versus 31.1 ± 1.8%, P < .05), and arachidonate was lower (1.2 ± 0.2% versus 6.0 ± 0.9%, P < .05). The total fatty acid composition of adipose tissue also differed between the 2 groups; palmitate was higher (25.2 ± 1.2% in cats with IHL versus 21.3 ± 0.6% in controls, P < .05), total monounsaturated fatty acids were higher (48.4 ± 1.0% versus 45.0 ± 0.8%, P < .05), linoleate was lower (13.3 ± 1.6% versus 17.5 ± 0.9%, P < .05), total (n-6) fatty acids were lower (13.8 ± 1.38% versus 18.4 ± 0.83%, P < .05), linolenate was lower (0.2 ± 0.04% versus 0.7 ± 0.06%, P < .05), and total (n-3) fatty acids were lower (0.3 ± 0.02% versus 1.3 ± 0.32%, P < .05). The fatty acid composition of both liver and adipose tissue was similar for stearate, oleate, linoleate, and linolenate in cats with IHL. These results support the hypothesis that the origin of hepatic triglyceride in cats with IHL is the mobilization of fatty acids from adipose tissue.     

Effect of amount and source of manganese and/or phytase supplementation on productive and reproductive performance and some physiological traits of dual purpose cross-bred hens in the tropics

1.?The effect of different amounts of added manganese (Mn) (0, 10, 20 and 40 mg/kg) in inorganic and organic form and phytase (0 and 300 U) was investigated on productive, reproductive and haematological traits on 480 hens and 60 cocks (Inchas breeds) divided into 12 groups: 10 and 20 Mn × 0 and 300 phytase × 2 Mn sources (8 groups), two negative controls (0 Mn × 2 levels of phytase) and two positive controls (40 Mn × 2 Mn sources).

2.?Phytase supplementation increased laying rate by 1·1% and egg weight by 0·4 g.

3.?Manganese supplementation at 10 mg/kg over dietary sources improved hatchability, at 20 mg/kg decreased death embryos and abnormality as those of hens supplemented with 40 mg/kg Mn. Inorganic Mn at 10 mg/kg significantly increased egg mass compared to the organic form. Inorganic Mn was more efficient in decreasing abnormal chicks than organic Mn. Phytase supplementation significantly increased hatchability of fertile eggs and decreased the number of abnormal chicks of groups fed on diets unsupplemented with Mn and those supplemented with 10 mg/kg Mn.

4.?Mn supplementation at 10 mg/kg over dietary sources significantly improved sperm mass motility and decreased abnormal sperm. Phytase significantly decreased lymphocyte cells and plasma AST.

5.?Mn supplementation of the control diet (containing only 16 mg/kg from raw materials) with 20 mg/kg of Mn from either organic or inorganic source is adequate to support egg production traits, egg quality, reproductive traits and economic efficiency of dual purpose cross-bred hens; however, phytase supplementation may reduce the required Mn supplementation to 10 mg/kg.     

A pharmacological study of chloramphenicol in Bubalus bubalis II*

The plasma levels of chloramphenicol were determined following i.m. administration in three groups of water buffalo (n= 4 per group). The absorption of chloramphenicol was relatively rapid since concentrations of 7.00 ± 0.62 μg/ml were detected in plasma after 1 h and peak concentrations of 9.25 ± 0.53 μg/ml were obtained 3 h following administration of 30 mg/kg. A concentration of at least 5 μg/ml was achieved at the end of 1 h and persisted up to 12 h (6.79 ± 1.19 μg/ml). With repetition of 10 and 20 mg/kg dose at 12 h, concentrations greater than 5 μg/ml persisted for an additional 8 and 12 h, respectively. The distribution studies of chloramphenicol in tissues and body fluids at 4 h post-injection (30 mg/kg i.m., n= 4, group IV), revealed that the highest concentration was seen in bile (31.67 ± 6.21 μg/ml), followed by liver, kidney, plasma, heart, skeletal muscle and brain (4.00 ± 0.50 μg/g).     

Investigation into selenium requirement of growing turkeys offered a diet supplemented with two levels of vitamin E

To evaluate dietary selenium (Se) requirement in turkeys offered a diet supplemented with two levels of vitamin E (VE), 96 newly hatched male BIG 6^® chicks (58.4 ± 4.12 g) were divided into eight groups of 12 animals each and fed maize soya diets containing 0.05, 0.10, 0.20 and 0.30 mg Se/kg from sodium selenate in combination either with the natural VE content (approximately 10 IU/kg) or with a VE addition of 50 IU/kg. Animals from all the groups were highly performant and their final body weights (1746 ± 190 g) after 35 days on experiment were not significantly different. According to its dietary supply, Se concentration in the liver and plasma increased dose dependently. Independent of dietary VE, the activities of GPx3 in plasma and of GPx1 in liver and breast muscle increased to a larger extent in turkeys supplemented with 0.10 and 0.20 mg Se/kg in relation to animals with low marginal Se supply (0.05 mg/kg). Supplementation of 0.30 mg Se/kg only slightly increased further selenoprotein activities. 2‐Thiobarbituric acid reactive substances in the liver were strongly reduced by dietary VE, but not by Se. Plasma aspartate aminotransferase (AST) and creatine kinase (CK) activities did not show muscular lesions in none of the groups. Although there were no signs of muscular lesions even in turkeys with marginal Se and moderate VE supply, the activity of selenoproteins in various organs increased up to 0.30 mg Se/kg diet, independent of VE supply. It was concluded that for growing turkeys the Se supply should meet at least a level of 0.20 mg/kg diet as currently recommended by the National Research Council and Gesellschaft für Ernährungsphysiologie. Vitamin E addition confirmed the particular function of the vitamin as a lipid antioxidant and should be taken into consideration when diets with high PUFA concentrations are fed.     

实用饲料中补充铜对斑点叉尾生长和体色的影响

在实用饲料(含铜11.1 mg/kg)中分别添加0(对照)、5、10、20和40 mg/kg铜[以五水硫酸铜(CuSO_4·5H_2O)形式],制成5种试验饲料,投喂平均体重为(98.1±0.5)g的斑点叉尾42 d,研究实用饲料中补充铜对斑点叉尾生长和体色的影响。每种饲料设3个重复,每个重复放养20尾鱼。结果表明:与对照组相比,饲料中添加10 mg/kg铜显著提高了鱼体的增重率(P0.05),显著降低了饲料系数(P0.05);饲料铜添加量进一步增加到40 mg/kg,鱼体的增重率则较添加量为10 mg/kg时显著降低(P0.05),同时饲料系数显著升高(P0.05)。肝脏和骨骼铜含量随着饲料中铜添加量的增加而上升,其中20、40 mg/kg铜添加组的肝脏铜含量显著高于对照组和5 mg/kg铜添加组(P0.05),40 mg/kg铜添加组的骨骼铜含量也显著高于对照组(P0.05),而肌肉铜含量保持基本不变(P0.05)。饲料中添加0~40 mg/kg铜对斑点叉尾背部皮肤、肌肉色度值、总叶黄素含量及背部皮肤酪氨酸酶活性均未产生显著影响(P0.05)。各组血清天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)活性和总胆红素(T-Bil)含量以及肌肉水分、粗蛋白质、粗脂肪和粗灰分含量无显著差异(P0.05)。10 mg/kg铜添加组具有最高的血清铜锌-超氧化物歧化酶(Cu,Zn-SOD)活性,显著高于其他各组(P0.05),而其他各组间则无显著差异(P0.05)。综上,在本试验条件下,斑点叉尾实用饲料中铜的添加量建议为10 mg/kg(饲料铜含量实测值为20.2 mg/kg)。     

Dispositions and residue depletion of enrofloxacin and its metabolite ciprofloxacin in muscle tissue of giant freshwater prawns (Macrobrachium rosenbergii)

Fates and residue depletion of enrofloxacin (ER) and its metabolite ciprofloxacin (CP) were examined in giant freshwater prawns, Macrobrachium rosenbergii, following either single oral (p.o.) administration of ER at a dosage of 10 mg/kg body weight (b.w.) or medicated‐feed treatment at the feeding concentration of 5 g/kg of feed for five consecutive days. The concentrations of ER and CP in prawn muscle tissues were measured simultaneously using high‐performance liquid chromatography (HPLC) equipped with a fluorescence detector. Muscle tissue concentrations of ER and CP were below the detection limit (LOD, 0.015 μg/g for ER; 0.025 μg/g for CP) after 360 and 42 h, following single p.o. administration respectively. Peak muscle concentration (C_max) of ER was 1.98 ± 0.22 μg/g whereas CP was measurable at concentrations close to the detection limit of the analytical method after p.o. administration at a single dosage of 10 mg/kg b.w. The concentration of ER in prawn muscle tissue with respect to time was analyzed with a non‐compartmental pharmacokinetic model. The elimination half‐life and area under the curve of ER were 39.33 ± 7.27 h and 168.7 ± 28.7 μg·h/g after p.o. administration at a single dose of 10 mg/kg·b.w. respectively. In medicated‐feed treated group, ER was detectable in prawn muscle tissue 11 days postdosing at the dose of 5 g/kg of feed for five consecutive days, which is the value corresponding to the maximum residue limit (MRL) of ER in animal products. The maximum concentrations of ER and CP were 2.77 ± 0.91 and 0.06 ± 0.006 μg/g during medicated‐feed treatment and postdosing respectively. The values of elimination half‐life and absorption half‐life of ER after single p.o. administration at a dosage of 10 mg/kg b.w. corresponded well with the values determined from medicated‐feed treated group, showing 41.01 ± 6.62 and 11.36 ± 3.15 h respectively in M. rosenbergii. Based on data derived from this study, to avoid the ER residue in prawn muscle, it should take at least 11 days postcessation of medicated feed containing ER at the dose concentration of 5 g/kg of feed twice a day at a rate of 1% of total body weight for five consecutive days to wash out the drug from the muscle of M. rosenbergii.     

Efficacy of Florfenicol for Control of Mortality Associated with Edwardsiella ictaluri in Three Species of Catfish

The efficacy of florfenicol for control of mortality associated with Edwardsiella icatluri was studied in fingerlings of Channel Catfish Ictalurus puntatus (Delta strain), Blue Catfish I. furcatus (D&B strain), and a hybrid catfish (Delta strain Channel Catfish × D&B strain Blue Catfish). On day 0, fish were immersion challenged in 65-L aquaria. For each of the three species of catfish, 10 aquaria were randomly assigned to two treatment groups, either treated with florfenicol at 0 mg/kg of body weight (unmedicated feed) or at 10 mg/kg (medicated feed). Fish were treated for 10 consecutive days, monitored for mortality during this treatment period, and observed for 14 d afterwards. Post observation, all survivors were humanely euthanized in tricaine methanesulfonate, cultured for E. ictaluri, and examined for gross pathology. The mean cumulative percent mortality from enteric septicemia of catfish (ESC) challenge among the three genotypes of catfish did not differ between Blue Catfish, hybrid, and Channel Catfish in treated or control groups. However, the florfenicol-treated fish had a significantly lower mean cumulative mortality (6%) than the controls (78%). All genotypes of catfish tested were responsive to treatment with florfenicol-medicated feed for control of mortality associated with ESC. There were no significant differences in mortality associated with hybrid catfish, blue catfish, and Channel Catfish (Delta strain).

Received July 20, 2014; accepted October 10, 2014     

Metabolism and depletion of albendazole in the muscle tissue of channel catfish following oral treatment

The residue depletion of albendazole (ABZ) and its metabolites was studied in channel catfish muscle tissue. Channel catfish were dosed once with 10 mg/kg ABZ via stomach tube with manual restraint. Muscle tissue samples were collected at 8, 16, 24, 48, 72, 96 and 120 h postdose. A high-performance liquid chromatographic method was used to assay ABZ and its major metabolites: ABZ sulfoxide (ABZ-SO), ABZ sulfone (ABZ-SO2) and ABZ aminosulfone (ABZ-2-NH2SO2) in the muscle tissue. The results indicate that ABZ and ABZ-SO were present in low concentrations, i.e. <15 and <10 microg/kg, respectively, at 8 h postdose in catfish muscle with and without skin. ABZ-SO2 was present at 1 microg/kg concentration levels until 48 h in muscle alone and 72 h in muscle with skin. ABZ-2-NH2SO2 was not detected at any withdrawal periods.     

日粮锰对肉仔鸡组织器官锰、铜、锌沉积的影响

选用 1日龄艾维茵肉仔鸡 ,采用单因子多水平随机化试验设计 ,随机分成 6组 ,每组 3个重复 ,每个重复 8只鸡。在玉米 豆粕型基础日粮中分别添加锰 (MnSO4 ·H2 O) 0 ,40 ,80 ,1 2 0 ,1 60 ,2 0 0mg/kg ,研究日粮锰对肉仔鸡组织器官锰、铜、锌沉积的影响。结果表明 :在肉仔鸡日粮中添加 40 2 0 0mg/kg的锰 ,对胫骨锰、肝脏锰和肾脏锰的沉积有显著的影响 (P <0 0 5) ;日粮锰的添加对肝铜和肾铜沉积无明显影响 (P >0 0 5) ,但日粮锰添加量超过 1 2 0mg/kg时 ,能够减少胫骨铜的沉积 (P <0 0 5) ;对胫骨、肝和肾中锌的沉积无明显影响(P >0 0 5)。     

Sulfamethazine blood/tissue correlation study in swine

Seventy market-weight hogs (90 to 113 kg) were used in a feeding study to determine the correlation of serum sulfamethazine concentrations with sulfamethazine concentrations in liver and muscle at time of slaughter. Test groups were fed medicated feeds prepared from commercial medicated premixes containing 110 g of sulfamethazine/metric ton for 30 days. Fifteen days before hogs were slaughtered, test groups were given maintenance feeds containing 1.1 to 13.9 g of sulfamethazine/metric ton and were fed these diets until slaughtered. Comparison of data from positive- and negative-control groups indicated that total withdrawal of sulfamethazine in the feed was not necessary for the liver to contain less than the allowed tolerance of 0.1 mg of sulfamethazine/kg of liver at slaughter. Feed concentrations of up to 2 g of sulfamethazine/metric ton could be tolerated in withdrawal feeds before liver sulfamethazine values exceeded 0.1 mg/kg of liver. Serum/tissue sulfamethazine ratios were erratic in hogs given 1.1 to 2.7 g of sulfamethazine/metric ton, but became less variable in hogs given greater than 5.7 g/metric ton. Feed concentrations greater than 8 g of sulfamethazine/metric ton produced values greater than 0.1 mg/kg of muscle and values of about 0.4 mg/kg of liver. When serum sulfamethazine concentrations alone were used as a predictor for tissue sulfamethazine values, 100% of the liver values exceeded 0.10 mg/kg of liver when sulfamethazine in serum was greater than 0.45 mg/L. However, 57.4% of samples having serum concentrations between 0.10 and 0.45 mg/L had associated sulfamethazine values greater than 0.1 mg/kg of liver. All hogs having serum sulfamethazine concentrations less than 0.1 mg/L had sulfamethazine concentrations less than 0.1 mg/kg of liver.     

Impact of molybdenum on the copper status of red deer (Cervus elaphus)

AIM: To determine the effect of increasing molybdenum (Mo) intakes on serum and liver copper (Cu) concentrations and growth rates of grazing red deer (Cervus elaphus).

METHODS: Molybdenum- and Cu-amended fertilisers were applied to six 1.1-ha paddocks in a 3 × 2 design. Three levels of Mo were applied on two paddocks at each level in mid April (designated Day 1); levels were: none (control), 0.5 (medium) and 1.0 (high) kg Mo/ha as sodium molybdate. In late May (Day 39), two levels of Cu (none and 3.0 kg Cu/ha, as copper sulphate) were applied to each of the three levels of Mo-treated paddocks. Pasture Mo, Cu and sulphur (S) concentrations were measured at about fortnightly intervals. In late June (Day 74), ten 6-month-old red deer hinds were placed on the six experimental pastures, and serum and liver Cu concentrations were monitored at about monthly intervals for 102 days. The hinds were weighed on four occasions during the trial.

RESULTS: Mean pasture Mo concentrations on Day 56 were 2, 4.6 and 11.3 mg/kg dry matter (DM) for the untreated control, medium and high Mo-treated pastures, respectively. Pasture Cu concentration was 95 mg/kg DM on Day 59, 53 mg/kg DM on Day 90, and 9 mg/kg DM by Day 153. Mean S concentration in pasture was 3.3 (range 3.03–3.45) g/kg DM. Copper application to pasture had no significant effect on serum and liver Cu concentrations in deer so data were pooled within Mo treatment. Mean initial (Day 74) serum Cu concentration was 9.2 µmol/L. In the deer grazing the control Mo pasture, this increased to 10.3 µmol/L on Day 112, before decreasing to 6.4 µmol/L on Day 176. In deer grazing the medium and high Mo-treated pastures, mean serum Cu concentrations were 3.8 and 3.9 µmol/L, respectively, on Day 112, and 2.5 and 3.3 µmol/L, respectively, on Day 176. Mean initial (Day 74) liver Cu concentration was 131 µmol/kg fresh tissue. In the deer grazing the control Mo pasture, this declined to 120 and 52 µmol/kg on Days 112 and Day 176, respectively. In deer grazing the medium and high Motreated pastures, liver Cu concentrations decreased to 55 and 52 µmol/kg fresh tissue, respectively, on Day 112, and 21 and 20 µmol/kg fresh tissue, respectively, on Day 176. Mean serum and liver Cu concentrations were not significantly different between deer grazing the medium and high Mo-treated pastures, and were lower (serum p=0.003, liver p<0.001) in those groups than in deer grazing the untreated control pastures. No clinical signs of Cu deficiency associated with lameness were observed. Deer grazing pastures that had Mo concentrations >10 mg/kg DM had lower (p=0.002) growth rates (100 vs 130 g/day) than those on pastures containing <2.4 mg Mo/kg DM.

CONCLUSION: Increasing pasture Mo concentrations from 2 mg/kg DM to ≥4.6 mg/kg DM significantly reduced serum and liver Cu concentrations in grazing deer. Reduced growth rate was observed at pasture Mo concentrations >10 mg/kg DM.     

Pharmacokinetic profiles of meloxicam after single IV and PO administration in Bilgorajska geese

The purpose of this study was two-fold: I) to determine the pharmacokinetic profile of meloxicam (MLX) in geese after intravenous (IV) and oral (PO) administration and II) to assess tissue residues in muscle, heart, liver, lung, and kidney. Ten clinically normal female Bilgorajska geese were divided into two groups (treated, n = 8; control, n = 2). Group 1 underwent a 3-phase parallel study with a 1-week washout period. In phase I, animals received MLX (0.5 mg/kg) by IV administration; the blood was collected up to 48 hr. In phases II and III geese were treated orally at the same dosage for the collection of blood and tissue samples, respectively. Group 2 served as control. After the extraction procedure, a validated HPLC method with UV detection was used for plasma and organ analysis. The plasma concentrations were quantifiable up to 24 hr after both the administrations. The elimination phase of MLX from plasma was similar in both the administration groups. The clearance was slow (0.00975 L/hr*Kg), the volume of distribution small (0.0487 L/kg), and the IV half-life was 5.06 ± 2.32 hr. The average absolute PO bioavailability was 64.2 ± 24.0%. Residues of MLX were lower than the LOQ (0.1 µg/kg) in any tested tissue and at any collection time. The dosage used in this study achieved the plasma concentration, which provides analgesia in Hispaniolan Amazon parrots for 5 out of 24 hr after PO administration. MLX tissue concentrations were below the LOD of the assay in tissue (0.03 µg/ml). A more sensitive technique might be necessary to determine likely residue concentrations in tissue.